Molecular marker testing and reporting completeness for adult-type diffuse gliomas in the United States.
Sign Up to like & getrecommendations! Published in 2022 at "Neuro-oncology practice"
DOI: 10.1093/nop/npac079
Abstract: Background A newly developed brain molecular marker (BMM) data item was implemented by US cancer registries for individuals diagnosed with brain tumors in 2018-including IDH and 1p/19q-co-deletion statuses for adult-type diffuse gliomas. We thus investigated… read more here.
Keywords: diffuse gliomas; testing reporting; reporting completeness; adult type ... See more keywords